Category Archives: Mesenchymal Stem Cells

By a News Reporter-Staff News Editor at Veterinary Week -- Research findings on Stem Cell Research are discussed in a new report. According to news originating from North Hills, California, by VerticalNews correspondents, research stated, "Successful derivations of specific neuronal and glial cells from embryonic stem cells have enormous potential for cell therapies and regenerative medicine. However, the low efficiency, the complexity of induction method, and the need for purification represent obstacles that make their application impractical." Our news journalists obtained a quote from the research, "In this study, we found that PDGFR alpha(+) cells derived from mouse embryonic stem cells (mESC) can serve as a useful source from which to induce cells that express gamma-aminobutyric-acid (GABA)-releasing (GABAergic) neuronal markers. PDGFR alpha(+) cells were induced from mESC on collagen IV-coated plates in mesenchymal stem cell (MSC) culture medium with limited exposure to retinoic acid, sorted by fluorescence-activated cell sorter and maintained in MSC culture medium containing Y-27632, a Rho-associated kinase inhibitor. We found that supplementation of vascular endothelial growth factor, fibroblast growth factor-basic, and sodium azide (NaN3) to MSC culture medium effectively differentiated PDGFR alpha(+) cells into cells that express GABAergic neuronal markers, such as Pax2, Dlx2, GAD67 NCAM, and … Continue reading →

Understanding Stem Cells Learn about Stem Cells -- what it is and what it can be used for. By: Cryo-Save South Africa … Continue reading →

Stem Cell Therapy Orlando | Stem Cell Treatments in Orlando Stem cell therapy in Orlando is available at Eterna MD. We have stem cell treatments available for those suffering from COPD, Type II Diabetes, Osteoarthriti... By: Eterna MD Regenerative Medicine … Continue reading →

Stem Cell Therapy Orlando Testimonial | Stem Cell Treatments Florida One of our patients has had successful results with our new revolutionary stem cell treatment in Orlando at Eterna MD. Please learn more at http://www.eterna... By: Eterna MD Regenerative Medicine … Continue reading →

Public release date: 20-Aug-2013 [ | E-mail | Share ] Contact: Gina Bericchia Gina.Bericchia@NationwideChildrens.org 614-355-0495 Nationwide Children's Hospital It's not often that one treatment offers therapeutic potential for multiple conditions. However, after more than two decades of research, Gail Besner, MD, principal investigator for the Center for Perinatal Research and pediatric surgeon for the Department of Pediatric Surgery at Nationwide Children's Hospital, and her team have found that this may just be the case with HB-EGF, or heparin-binding EGF-like growth factor. Having discovered the growth factor in 1990, Dr. Besner most recently conducted two studies in mice published in June in the Journal of Pediatric Surgery that reveal the potential of HB-EGF to protect the intestines from diverse types of injury. The first offers evidence that treatment with the growth factor may help the intestines protect themselves from damage after exposure to radiation therapy. "Many patients are treated with radiation therapy for pelvic and abdominal cancers each year, and over half suffer from injury to the intestines as a result, which may limit their ability to receive additional therapy," Dr. Besner says. "In the future, treatment with HB-EGF may protect the intestines from this injury, enabling patients to receive more … Continue reading →

Stem Cell Therapy: Where's the Evidence? Dr. Tony Dans of the University of the Philippines College of Medicine discusses dilemmas in research and regulation of stem cell therapy in the Philippines.... By: Antonio Dans … Continue reading →

NEW YORK, Aug. 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Stem Cell Markets http://www.reportlinker.com/p090979/Stem-Cell-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential. The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and … Continue reading →

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will give the keynote address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine conference on Monday, August 19, 2013, at 12:15 p.m. EDT in Cleveland, Ohio. Dr. West will discuss the potential use of embryonic mesenchymal progenitor cells, generated using BioTimes PureStemtechnology, in regenerative medicine and will contrast the properties of those cells with adult-derived mesenchymal stem cells. He will also discuss how those cells can be utilized in the search for genes potentially useful in induced tissue regeneration (iTR). The presentation will be available on BioTimes website at http://www.biotimeinc.com/scientific-presentations. MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine, August 19-21, 2013, is being held at the Cleveland Marriott Downtown at Key Center and is presented by Case Western Reserve University and the National Center for Regenerative Medicine. About BioTime, Inc BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue … Continue reading →

Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Dee... By: Neurogen Brain and Spine Institute … Continue reading →

by Buena Bernal Posted on 08/15/2013 7:59 PM |Updated 08/16/2013 12:05 AM PROBE STEM CELL THERAPY. Rep Paulino 'Doy' Leachon files a resolution to probe the conduct of stem cell therapy in the Philippines. Photo grabbed from islandsentinel.com MANILA, Philippines - Rep Paulino Salvador "Doy" Leachon of Oriental Mindoro's 1st district filed on Thusday, August 15, a house resolution calling for a congressional inquiry in aid of legislation on the conduct of stem cell therapy in the country. House Resolution 215 was filed a day after Leachon's scheduled privilege speech, calling for the resignation of Health Secretary Enrique Ona over the cabinet official's stand on stem cell therapy. READ: Leachon asks Ona to resign over stem cell issue The 40-year-old lawmaker also urged concerned government agencies to step up their regulatory oversight. These agencies include the Department of Health (DOH), the Food and Drug Administration (FDA), and the Professional Regulation Commission (PRC). First attempt to regulate Government regulation of stem cell treatment is still in its infancy stage, with the guidelines for accreditation of facilities released only in March. It is DOH's first attempt at regulating the practice, despite the therapy having been administered by Filipino physicians for years now. … Continue reading →